"Nadolol" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
A non-selective beta-adrenergic antagonist with a long half-life, used in cardiovascular disease to treat arrhythmias, angina pectoris, and hypertension. Nadolol is also used for MIGRAINE DISORDERS and for tremor.
| Descriptor ID |
D009248
|
| MeSH Number(s) |
D02.033.100.624.698.601 D02.033.755.624.698.601 D02.092.063.624.698.601
|
| Concept/Terms |
|
Below are MeSH descriptors whose meaning is more general than "Nadolol".
Below are MeSH descriptors whose meaning is more specific than "Nadolol".
This graph shows the total number of publications written about "Nadolol" by people in this website by year, and whether "Nadolol" was a major or minor topic of these publications.
To see the data from this visualization as text,
click here.
| Year | Major Topic | Minor Topic | Total |
|---|
| 1999 | 0 | 1 | 1 |
| 2006 | 0 | 1 | 1 |
To return to the timeline,
click here.
Below are the most recent publications written about "Nadolol" by people in Profiles.
-
Holinstat M, Voss B, Bilodeau ML, Hamm HE. Protease-activated receptors differentially regulate human platelet activation through a phosphatidic acid-dependent pathway. Mol Pharmacol. 2007 Mar; 71(3):686-94.
-
Chugani DC, Niimura K, Chaturvedi S, Muzik O, Fakhouri M, Lee ML, Chugani HT. Increased brain serotonin synthesis in migraine. Neurology. 1999 Oct 22; 53(7):1473-9.
-
Saksena S, Klein GJ, Kowey PR, Calvo RA, Boccadamo R, Brown JE, Sharma AD, Gadhoke A, Olukotun AY. Electrophysiologic effects, clinical efficacy and safety of intravenous and oral nadolol in refractory supraventricular tachyarrhythmias. Am J Cardiol. 1987 Feb 01; 59(4):307-12.